StockWatch
·
HomeLiveWeekly
Pharmaceuticals
Board Meeting25 May 2026, 01:23 pm

Nectar Lifesciences Board Meeting on 30 May 2026 for Audited Results

AI Summary

Nectar Lifesciences Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the Audited Financial Results for the financial year 2025-26. The meeting will also cover the Financial Statements of the Company for the same period and related matters, as per SEBI regulations.

Key Highlights

  • Board meeting scheduled for May 30, 2026.
  • Meeting to approve audited financial results for FY 2025-26.
  • Financial statements for FY 2025-26 will be considered.
  • Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
View BSE Filing
NECLIFE
Pharmaceuticals
NECTAR LIFESCIENCES LTD.

Price Impact

More from NECLIFE

Business Update1d ago, 8:40 pm

Nectar Lifesciences Shifts Registered Office

Insider Trading24 Jun, 6:30 pm

Nectar Lifesciences Closes Trading Window for Insider Trading

Quarterly Result30 May, 3:01 pm

Nectar Lifesciences: FY26 Audited Results Approved

More in Board Meeting

SAMBHV1d ago, 8:00 pm

Sambhv Steel Tubes Board Meeting on July 15, 2026 to Consider Fund Raising

VINEETLAB1d ago, 7:40 pm

Vineet Laboratories Board Meeting on July 15, 2026 for Audited Results

LTIM1d ago, 7:10 pm

LTM (ex-LTIMindtree) Q1 strong: consol PAT +17% YoY to ₹1,469 Cr, revenue +18%, margins expand